Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milos Petkovic

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Bioengineering and Biotechnology|October 4, 2024
Functionalization of silk with actinomycins from <i>Streptomyces anulatu</i>s BV365 for biomedical applicationsTatjana Ilic-Tomic, Ana Kramar, Mirjana Kostic, et al.
Pharmaceutics|December 23, 2022
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological EvaluationDusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, et al.
Future Medicinal Chemistry|January 31, 2025
Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agentsMilan Beljkas, Dusan Ruzic, Ana Djuric, et al.
Pharmaceutics|February 26, 2025
Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain DeliveryTijana Stanković, Tanja Ilić, Branka Divović Matović, et al.
The FEBS Journal|March 14, 2025
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsMaria Teresa Borrello, Dusan Ruzic, Hannah Paish, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Bioengineering and Biotechnology|October 4, 2024
Functionalization of silk with actinomycins from <i>Streptomyces anulatu</i>s BV365 for biomedical applicationsTatjana Ilic-Tomic, Ana Kramar, Mirjana Kostic, et al.
Pharmaceutics|December 23, 2022
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological EvaluationDusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, et al.
Future Medicinal Chemistry|January 31, 2025
Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agentsMilan Beljkas, Dusan Ruzic, Ana Djuric, et al.
Pharmaceutics|February 26, 2025
Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain DeliveryTijana Stanković, Tanja Ilić, Branka Divović Matović, et al.
The FEBS Journal|March 14, 2025
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsMaria Teresa Borrello, Dusan Ruzic, Hannah Paish, et al.
Pageof 2